OBI PHARMA, INC.
台灣浩鼎生技股份有限公司
Leave your email for change alerts (optional)
2002Founded
NT$1.3BPaid-in capital
0Plants
1Certifications
9Patents
NT$20–100MRevenue band
- Unified Business No.
- 13110677
- Industry
- Tobacco Manufacturing (1,186)
- Listing
- Listed (TPEx) (890) 4174
- Founded
- 2002-04-29
- Paid-in capital
- NT$ 1,315,796,870
- Phone
- (02)2655-8799
- Website
- https://www.obipharma.com
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$20–100M
- Ownership
- Group subsidiary / corporate-held · Yi Tai Tou Tzu Co., Ltd.
- Representative tenure
- In office since 2024-01 (2 yrs); last handover 2024-01
- Growth & profitability
- Revenue 2026-09 YoY -69.7%, year-to-date -27.5%
Gross margin -199.3%, operating margin -3192.1%, net margin -3705.6% (2026-Q2 YTD) - Compliance record
- Labour Standards Act penalties: 1 case(s) in 5 years, latest 2025-01-17, fines NT$ 20,000 (Art. 38) — matched by company name
Certifications 1
- FDA (53)Self-reported
Processes & materials 1
- Biotechnology (664) · Company nameSelf-reported
Patents 9
- 2026 Bispecific dendritic cell engager and use thereof
- 2025 Companion diagnostic analysis for GLOBO-H-related cancer therapy
- 2024 Pharmaceutical composition for treating and preventing coronavirus infection
Similar companies 10
- Yung Sheng Biotech Co., Ltd. Listed (TWSE) NT$100–500M
Shared: Biotechnology, FDA - PHARMAENGINE, INC. Listed (TPEx) NT$1–5B
Shared: Biotechnology, FDA, Western pharmaceutical wholesale - LUMOSA THERAPEUTICS CO., LTD. Listed (TPEx) NT$20–100M
Shared: Biotechnology, Western pharmaceutical wholesale - PELL BIO-MED TECHNOLOGY CO., LTD. Listed (TWSE) NT$20–100M
Shared: Biotechnology, Western pharmaceutical wholesale - Chuan Yu Biotech Holdings Co., Ltd. Listed (TWSE) NT$1–5B
Shared: Biotechnology - Han Kang Biotech Co. (Cayman) Listed (TWSE) NT$20–100M
Shared: Biotechnology - TLC BioSciences Corp. Emerging stock (TPEx) NT$20–100M
Shared: FDA - ANNJI PHARMACEUTICAL CO., LTD. Emerging stock (TPEx) < NT$20M
Shared: Biotechnology, Western pharmaceutical wholesale - GREAT NOVEL THERAPEUTICS BIOTECH & MEDICALS CORPORATION Emerging stock (TPEx) < NT$20M
Shared: Biotechnology, Western pharmaceutical wholesale - Mediera Corporation Listed (TPEx) NT$0.5–1B estimated
Shared: Biotechnology, Western pharmaceutical wholesale